Clinical Profile of Patients Considered for BIAsp 30: Baseline Characteristics from China, Japan and Poland from the Improve™ Study.

Autor: Wenying, Yang, Kawamori, Ryuzo, Valensi, Paul, Gylvin, Titus, Ligthelm, Robert
Předmět:
Zdroj: Diabetes; Jun2007 Supplement 1, Vol. 56, pA627-A627, 1/4p, 1 Chart
Abstrakt: The article presents the findings of a study which investigated baseline characteristics of patients starting biphasic insulin aspart 30 (BIAsp 30) and its efficacy for treatment of type 2 diabetes conducted in China, Japan and Poland. The subjects were patients given insulin± oral anti-diabetics (OAD), OADs alone or had not received any previous treatment. Common reasons for using BIAsp 30 included improvement of fasting blood glucose and post-prandial blood glucose.
Databáze: Complementary Index